Genelux Corp. (GNLX)
2.56
+0.04
(+1.59%)
USD |
NASDAQ |
Oct 02, 16:00
2.56
0.00 (0.00%)
After-Hours: 20:00
Genelux Market Cap : 115.46M for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 115.46M |
| October 01, 2026 | 113.66M |
| September 30, 2026 | 114.11M |
| September 29, 2026 | 110.50M |
| September 28, 2026 | 111.41M |
| September 25, 2026 | 111.86M |
| September 24, 2026 | 109.60M |
| September 23, 2026 | 113.44M |
| September 22, 2026 | 117.72M |
| September 21, 2026 | 115.46M |
| September 18, 2026 | 114.11M |
| September 17, 2026 | 114.11M |
| September 16, 2026 | 105.54M |
| September 15, 2026 | 111.41M |
| September 14, 2026 | 114.56M |
| September 11, 2026 | 112.31M |
| September 10, 2026 | 111.86M |
| September 09, 2026 | 113.66M |
| September 08, 2026 | 114.56M |
| September 04, 2026 | 110.05M |
| September 03, 2026 | 113.66M |
| September 02, 2026 | 115.01M |
| September 01, 2026 | 117.27M |
| August 31, 2026 | 117.95M |
| August 28, 2026 | 119.98M |
| Date | Value |
|---|---|
| August 27, 2026 | 129.90M |
| August 26, 2026 | 123.13M |
| August 25, 2026 | 122.68M |
| August 24, 2026 | 122.68M |
| August 21, 2026 | 122.68M |
| August 20, 2026 | 123.58M |
| August 19, 2026 | 120.88M |
| August 18, 2026 | 117.27M |
| August 17, 2026 | 121.78M |
| August 14, 2026 | 123.58M |
| August 13, 2026 | 118.62M |
| August 12, 2026 | 121.78M |
| August 11, 2026 | 119.52M |
| August 10, 2026 | 122.68M |
| August 07, 2026 | 119.28M |
| August 06, 2026 | 121.07M |
| August 05, 2026 | 112.55M |
| August 04, 2026 | 126.45M |
| August 03, 2026 | 133.62M |
| July 31, 2026 | 131.83M |
| July 30, 2026 | 136.76M |
| July 29, 2026 | 126.90M |
| July 28, 2026 | 130.93M |
| July 27, 2026 | 132.28M |
| July 24, 2026 | 129.59M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arcutis Biotherapeutics, Inc. | 3.160B |
| ACADIA Pharmaceuticals, Inc. | 3.434B |
| Alnylam Pharmaceuticals, Inc. | 29.38B |
| Savara, Inc. | 987.97M |
| Vericel Corp. | 2.055B |
Market Cap Related Metrics
| PS Ratio | 13176.76 |
| PEG Ratio | -2.277 |
| Price to Book Value | 7.166 |
| Price | 2.56 |
| Earnings Yield | -33.90% |
| PEGY Ratio | -2.277 |